A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending watchdog said it “does not currently demonstrate value for the NHS”. The news ...
Donanemab is a targeted antibody drug which slows down the early stages of Alzheimer’s. The drug, and another new drug for ...
A European Medicines Agency (EMA) committee has recommended the approval of Novo Nordisk’s concizumab as a prophylactic, or ...
Europe’s drug regulator recommended two novel vaccines for influenza alongside updated composition for two COVID-19 vaccines ...
Novo Nordisk's Alhemo (concizumab) receives a positive opinion from the EMA's CHMP for hemophilia A or B with inhibitors. The ...
After hitting a wall with the FDA last year, Novo Nordisk has picked up backing from European drug reviewers for its novel ...
The European Medicines Agency (EMA) has upheld an earlier recommendation to deny marketing authorization for Masitinib AB ...
Rising pharmaceutical prices, particularly for novel therapies and cancer treatments, are driving increased health spending ...
Bayer has submitted an MAA to the EMA for elinzanetant, targeting moderate to severe vasomotor symptoms linked to menopause.
Bayer on Tuesday said it had applied for marketing authorization with the European Medicines Agency (EMA) for its menopause ...
Kellanova, which owns the Kellogg’s, Pringles and Cheez-It brands, has reappointed Carat as its European media agency. Mediasense supported the pitch. Carat and Kellanova have worked together for 16 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback